Walleye Trading’s Select Medical SEM Stock Holding History

Walleye Trading’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,166	Closed	-$62K	–	4451
2019 Q1	$62K	Buy	8,166 +2,784	+52%	+$22.4K	﹤0.01%	3654
2018 Q4	$45K	Buy	+5,382	New	+$51.5K	﹤0.01%	4181
2018 Q3	–	Sell	-19,488	Closed	-$191K	–	5513
2018 Q2	$191K	Buy	+19,488	New	+$191K	﹤0.01%	3679

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Walleye Trading's SEM Position: Q4 2018 in Review

Walleye Trading sold out of Select Medical (SEM) in Q4 2018, closing a stake of 5,059 shares — an estimated $48.4K sold.

Walleye Trading first reported a position in SEM in Q2 2015 and held it in 5 quarters. The position peaked at $89K in Q2 2016. 208 funds tracked by Wall St. Rank hold SEM as of Q4 2018.

Walleye Trading reported no remaining Select Medical position as of Q4 2018 after selling out during the quarter.
Walleye Trading sold 5,059 Select Medical shares in Q4 2018, an estimated $48.4K.
Walleye Trading first reported a position in Select Medical in Q2 2015 and held it in 5 quarters.
Walleye Trading's Select Medical position peaked at $89K in Q2 2016.
208 funds tracked by Wall St. Rank held Select Medical as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.